Hypertrophic scarring affects a large proportion of patients following burns, trauma, or surgery and arises from prolonged fibroblast hyperactivity and excessive extracellular matrix accumulation.

A joint effort by a team of academic and industrial researchers led by Associate Professor Yoshinori Yoshida (Department of Cell Growth and Differentiation) created a new modeling system, combining ...

Objective Current guidelines recommend precautionary disqualification from competitive sports in patients with hypertrophic cardiomyopathy (HCM). We assessed the incidence of cardiovascular events in ...

Hypertrophic cardiomyopathy is an underdiagnosed genetic disorder, resulting from mutations in sarcomeric proteins. It has a highly variable clinical presentation, with some individuals remaining ...

What is Hypertrophic Cardiomyopathy (HCM)? Hypertrophic cardiomyopathy (HCM) is a condition that affects the muscle layer of the heart in patients without any underlying heart problems or systemic ...

You can manage the risks of hypertrophic cardiomyopathy (HCM) with treatment and lifestyle changes. Here’s how to make the most of your next medical checkup. HCM is a genetic condition in which the ...

Please provide your email address to receive an email when new articles are posted on . Hypertrophic cardiomyopathy is the most common monogenic CV disorder, yet perhaps the most frequently ...

August 26, 2009 — Keloids and hypertrophic scars result from an exuberant healing response and are often difficult to distinguish and treat, according to a review of recommendations for family ...

Hypertrophic cardiomyopathy (HCM) is a primary disease of cardiac muscle characterized by a thickening of the left ventricular wall and often predominantly affecting the interventricular septum. This ...